Abstract:Objective To explore the feasibility of peritumoral anti-angiogenesis of hepatic VX2 tumor by transcatheter arteri-al chemoembolization(TACE) in rabbits. Methods Liver tumor models were made by VX2 squamous. Thirty male or female New Zealand white rabbits with body weight 2-3 kg were randomly divided into 3 groups, 10 in each group, as experimental group A(TACE combined with Sorafenib ultrasound microbubbles), experimental group B(TACE combined with Sorafenib) and positive control group C(0.9%sodium chloride solution combined with TACE). MSCT was performed after treatment for 4-week, the lipiodol deposition volume(VI) and residual tumor volume(VR) were calculated, expression levels of vascular endothelial growth factor(VEGF) were then determined by immunohistochemistry. Results VI of group A was (4.5 ± 2.1) cm3,which was significantly bigger than that of group B and group C[(1.5 ± 1.8) cm3, (1.4 ± 1.2) cm3;P<0.01], while there was no significant difference be-tween group B and group C(P > 0.05). VR of group A was (2.8 ± 2.7) cm3,which was significantly smaller than that of group B and group C[(5.1 ± 3.8) cm3, (8.9 ± 4.6) cm3;P<0.05, P<0.01]. VR of group B was significantly smaller than that of group C (P < 0.05). There was no extrahepatic metastasis in group A, while 3 in group B and 10 in group C were found extrahepatic metastasis. The expression intensity of VEGF in group A was 0.11 ± 0.06, group B of 0.21 ± 0.08 and group C of 1.48 ± 0.32. The expression level of group A was significantly lower than that of group C(t=5.14, P<0.001), and expression level of group B was also significantly lower than that of group C(t=3.36, P<0.001). Conclusion It is demonstrated that the peritumoral anti-agiogenic barrier can be formed by transcatheter arterial chemoembolization combined with Sorafenib ultrasound microbubbles in hepatic VX2 tumor rabbits.

Study on peritumoral anti-angiogenesis of hepatic VX2 tumor by transcatheter arterial chemoembolization combined with Sorafenib ultrasound microbubbles in rabbits